GlobeNewswire Inc.··Glancy Prongay Wolke & Rotter LlpATRA Stock Crashes 97% Total as FDA Rejects Cancer Drug Twice; Class Action Lawsuit Looms
Atara Biotherapeutics stock collapsed 97% across two FDA rejections for tabelecleucel. Class action deadline: May 22, 2026.
ATRAsecurities fraudclass action lawsuit